Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Equine rhinopneumonitis - influenza vaccine - tetanus toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Haemophilus influenzae Type b vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Haemophilus influenzae Type b (Hib)/diphtheria/tetanus/pertussis vaccine vial+prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Haemophilus influenzae Type b (Hib)/diphtheria/tetanus/pertussis vaccine prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Haemophilus influenzae Type b (Hib)/diphtheria/tetanus/pertussis vaccine vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Influenza split virion vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Inactivated Influenza surface antigen sub-unit vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Haemophilus influenzae Type b vaccine injection (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Influenza (split virion) vaccine injection suspension 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Inactivated Influenza surface antigen sub-unit vaccine prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Influenza virus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Haemophilus b polysaccharide conjugate (diphtheria toxoid conjugate) vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Haemophilus b oligosaccharide conjugate(diphtheria CRM>197< protein conjugate) vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Swine influenza virus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Influenza vaccine injection 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Influenza vaccine prefilled syringe 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Influenza vaccine Vials 5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Influenza vaccine Vials 25mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Influenza virus vaccine 45mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 0.6ml/0.5ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 7.5ml/5ml (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Haemophilus b polysaccharide + tetanus toxoid 10mcg/24mcg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Inactivated Influenza vaccine (split virion) prefilled syringe 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Inactivated Influenza vaccine (surface antigen) prefilled syringe 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Diphtheria and tetanus toxoid 0.5vial/haemophilus b conjugate injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Influenza virus vaccine trivalent 45mcg/0.5mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Influenza virus vaccine triv 45mcg/0.5mL injection solution 0.5mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Influenza vaccine injection 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Influenza vaccine prefilled syringe 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Influenza vaccine Vials 5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Influenza vaccine Vials 25mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Haemophilus influenzae type b vaccine |
Is a |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Inactivated influenza split virion vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Inactivated influenza surface antigen vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Intranasal influenza live virus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Influenza live virus vaccine 0.5mL nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Influenza split virion vaccine |
Is a |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Influenza surface antigen vaccine |
Is a |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Influenza vaccine poisoning |
Causative agent (attribute) |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Accidental influenza vaccine poisoning |
Causative agent (attribute) |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Intentional influenza vaccine poisoning |
Causative agent (attribute) |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Influenza vaccine poisoning of undetermined intent |
Causative agent (attribute) |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Allergy to influenza vaccine |
Causative agent (attribute) |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Animal immunization for influenza |
Direct substance |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Administration of influenza vaccine |
Direct substance |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Administration of first dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Administration of second dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
Direct substance |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Administration of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
Direct substance |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Administration of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Administration of fourth dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
Direct substance |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Inactivated Influenza surface antigen virosome vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Inactivated Influenza surface antigen virosome vaccine prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Adverse reaction to influenza virus vaccine |
Causative agent (attribute) |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Influenza virus H5N1 vaccine |
Is a |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Intranasal influenza live virus vaccine 0.2mL nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Product containing Influenza virus vaccine in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Animal immunization for influenza |
Direct substance |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Administration of influenza vaccine |
Direct substance |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Animal immunization for influenza |
Direct substance |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Administration of influenza vaccine |
Direct substance |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Influenza A virus subtype H1N1 vaccine |
Is a |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
|
Allergy to influenza vaccine |
Causative agent (attribute) |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Administration of influenza vaccine via nasal route |
Direct substance |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Influenza virus vaccine triv 45mcg/0.5mL injection solution 0.5mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |
Influenza virus vaccine trivalent 45mcg/0.5mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Influenza virus vaccine |
Inferred relationship |
Some |
1 |